Chemotherapy is modern medicine’s first line of defense against cancer: chemotherapy drugs kill dividing cells by damaging DNA, preventing tumor cells from multiplying and tumors themselves from growing. To pick which chemotherapy regimens to use, oncologists rely on broad guidelines, based on the average success rates of chemotherapies. But these guidelines don’t take into account the genetic diversity of tumors, which can make some tumors drug resistant.
“Whole genome sequencing of pharmacogenetic drug response in racially diverse children with asthma” has been published by the American Journal of Respiratory and Critical Care Medicine (ARJCCM). “This is a huge win for the NHLBI’s TOPMed program, UCSF, and our lab”, said senior author Esteban G. Burchard, MD, MPH.
The UCSF School of Pharmacy 2018 Mary Anne Koda-Kimble Seed Award for Innovation marked its fourth year of funding with the February 26 announcement by Dean B. Joseph Guglielmo, PharmD, of eight research award recipients. Awardees are from across the School and range from full faculty members to PharmD and PhD students.